Is Veru Inc (VERU) Stock About to Get Hot Tuesday?

The market has been down on Veru Inc (VERU) stock recently. VERU gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Veru Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on VERU!

See Full VERU Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With VERU Stock Today?

Veru Inc (VERU) stock is unmoved 0% while the S&P 500 is lower by -0.62% as of 4:00 PM on Monday, Sep 25. VERU is unmoved $0.00 from the previous closing price of $0.84 on volume of 606,349 shares. Over the past year the S&P 500 has gained 17.93% while VERU is lower by -92.17%. VERU lost -$1.38 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Veru Inc click here.

More About Veru Inc

Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. Click Here to get the full Stock Report for Veru Inc stock.